Myopia
Conditions
Keywords
Juvenile, Traditional Chinese Medicine, Plum-blossom needle
Brief summary
The purpose of this study is to determine whether plum-blossom needle is effective in the treatment of juvenile myopia and compare the efficacy with Tropicamide Eye Drops.
Detailed description
Plum-blossom needle is a historical treatment technology of Traditional Chinese Medicine, and has been applied to ophthalmic diseases, such as myopia and glaucoma, for nearly one hundred years.
Interventions
* acupoint selection: Zhengguang 1, Zhengguang 2, GB20, GV14, LI4. * plum-blossom needle manipulation methods: After the skin has been wiped with 75 % alcohol, plum-blossom needles will be tapped perpendicularly on the skin at the selected acupoints with wrist force and then lifted immediately. Each point will be tapped repeatedly for 20 to 50 times and both sides of cervical vertebra and temporal region, Suprao-infraorbital margin will be tapped repeatedly. Acupuncturists should tap the points gently to make patients feel only a little pain and stop when the skin gets flushed but is not bleeding.
Instill one drop in both eyes every night before bed.
Sponsors
Study design
Eligibility
Inclusion criteria
* The result of retinoscopy is myopic refractive error, near visual acuity and other visual functions must be normal * Distance visual acuity can be corrected to normal using negative spherical or cylindrical lenses * Myopia diopter spherical lenses must be ≤-3.00 D which measured under cycloplegia * Subjects must be between 8 and 20 years of age
Exclusion criteria
* Diopter spherical lenses be \>-3.00 D , or uncorrected distance visual acuity \<0.1, or pathologic myopia with eye complications * Diopter spherical lense ≥1.50 D or cylindrical lenses ≥1.00 D, as measured under cycloplegia * The affected eyes have other diseases which affect the determination of acupuncture efficacy * Subjects with serious systemic diseases, such as cerebrovascular, liver, kidney, hematopoietic system, and psychiatric diseases * Longterm use of other related drugs or treatments, which have not been terminated * Parents or subjects refuse to participate this trial * Participating other ongoing clinical trials
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes of vision acuity | Every 30 days for 150 days | International Standard Visual Acuity Chart |
| Changes of cycloplegic refractive errors | Every 30 days for 150 days | Measured using subjective refraction |
Secondary
| Measure | Time frame |
|---|---|
| Changes of accommodation responses | Every 30 days for 150 days |
| Changes of accommodation facility | Every 30 days for 150 days |
| Changes of ciliary body thickness | Every 30 days for 150 days |
| Changes of axial length | Every 30 days for 150 days |
Countries
China